Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05WUN
|
|||
| Former ID |
DIB012075
|
|||
| Drug Name |
OTI-020
|
|||
| Synonyms |
Provacel; Mesenchymal stem cell therapies (cardiac repair); OTI-021; Prochymal (MI); Prochymal (myocardial infarction); Mesenchymal stem cell therapies (cardiac repair), Osiris; Mesenchymal stem cell therapies (cardiac repair), Osiris/Boston Scientific; Remestemcel-L (myocardial infarction), Osiris; MSC therapy (cardiac repair), Osiris/Johns Hopkins/Boston Scientific; Mesenchymal stem cell therapies (cardiac repair), Osiris/Johns Hopkins/Boston Scientific
Click to Show/Hide
|
|||
| Indication | Myocardial disease [ICD-11: BC43.20; ICD-10: I42.3, I42.4] | Phase 3 | [1] | |
| Company |
Osiris Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.